CMS Announces New Rules For Medicare Advantage Plans That Aim To Protect Sick Beneficiaries From High Out-of-Pocket Costs, Limit Number Of Plans
Main Category: Medicare / Medicaid / SCHIPArticle Date: 01 Apr 2009 - 6:00 PDT
| Patient / Public: | ![]() |
3 (1 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
CMS on Monday announced that insurers looking to offer Medicare Advantage plans this year must cap out-of-pocket charges and that the agency will eliminate MA plans that have 10 or fewer beneficiaries, the Wall Street Journal reports. CMS said insurers will be asked by the government to scale back their charges if they do not cap beneficiaries' annual out-of-pocket costs at $3,400 or less, or if they charge beneficiaries more than traditional Medicare for services such as dialysis and home health care. Insurers also will not be allowed to charge sick, low-income beneficiaries more than what they would contribute under traditional Medicare, according to the new rules (Zhang, Wall Street Journal, 3/31).
In addition, CMS will prohibit a practice by Medicare prescription drug plans that charges both a higher copayment for brand-name medication and the difference between the cost of the brand-name drug and a generic version. Higher copays still will be permitted, but the extra cost for the difference between the drugs will no longer be charged to beneficiaries (Alonso-Zaldivar, AP/Boston Globe, 3/30). Insurers offering prescription drug plans will be required to list on their Web sites "all the tools used by the plan to lower costs and improve outcomes," according to CMS. Insurers also will be required to provide more detailed, easier-to-understand information about coverage during the drug benefit's so-called "doughnut hole" coverage gap, in which beneficiaries pay 100% of prescription drug costs.
CMS said it will bar a number of enrollment incentives for the plans, while considering a separate incentives program to encourage plans to focus more on preventive care. The agency said it also will conduct stricter audits of MA and prescription drug plan data (Reichard, CQ HealthBeat, 3/30).
CMS officials said that reducing the number of MA plans offered would lessen confusion among beneficiaries. According to officials, nearly 1,400 of the 7,000 MA plans offered have fewer than 10 beneficiaries. "These low-volume plans crowd the field and make selecting a plan much more difficult," CMS said in a statement (AP/Boston Globe, 3/30). The statement said that less than 1% of MA beneficiaries would be affected by dropping the plans. According to CMS, eliminating the low-volume plans would allow beneficiaries to see positive changes in benefits, formularies and out-of-pocket costs (CQ HealthBeat, 3/30).
According to the Journal, the "changes represent the first steps by President Barack Obama's administration to rein in Medicare Advantage." Obama "has criticized the plans for spending too much while providing too little care" for beneficiaries, the Journal reports (Wall Street Journal, 3/31). Jonathan Blum, CMS' acting director of the Center for Drug and Health Plan Choice, said, "The overall theme here is to make sure there is less confusion and more transparency, so consumers can make well-informed choices" (AP/Boston Globe, 3/30).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our medicare / medicaid / schip section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/144520.php>
APA
http://www.medicalnewstoday.com/releases/144520.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





